Literature DB >> 28824747

Antagonists of Orexin Receptors as Potential Treatment of Sleep Disorders, Obesity, Eating Disorders, and Other Neurological and Psychiatric Disorders.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2016        PMID: 28824747      PMCID: PMC5560473          DOI: 10.1021/acsmedchemlett.6b00325

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia.

Authors:  Anthony J Roecker; Christopher D Cox; Paul J Coleman
Journal:  J Med Chem       Date:  2015-09-15       Impact factor: 7.446

Review 2.  Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs.

Authors:  Anil Kumar; Priyanka Chanana; Supriti Choudhary
Journal:  Pharmacol Rep       Date:  2015-09-28       Impact factor: 3.024

Review 3.  Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders.

Authors:  Tian-Rui Xu; Yang Yang; Richard Ward; Linghuan Gao; Ying Liu
Journal:  Cell Signal       Date:  2013-08-01       Impact factor: 4.315

  3 in total
  2 in total

1.  β-Functionalization of Saturated Aza-Heterocycles Enabled by Organic Photoredox Catalysis.

Authors:  Natalie Holmberg-Douglas; Younggi Choi; Brian Aquila; Hoan Huynh; David A Nicewicz
Journal:  ACS Catal       Date:  2021-02-24       Impact factor: 13.700

2.  Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa.

Authors:  Trevor Steward; Gemma Mestre-Bach; Roser Granero; Isabel Sánchez; Nadine Riesco; Cristina Vintró-Alcaraz; Sarah Sauchelli; Susana Jiménez-Murcia; Zaida Agüera; Jose C Fernández-García; Lourdes Garrido-Sánchez; Francisco J Tinahones; Felipe F Casanueva; Rosa M Baños; Cristina Botella; Ana B Crujeiras; Rafael de la Torre; Jose M Fernández-Real; Gema Frühbeck; Francisco J Ortega; Amaia Rodríguez; José M Menchón; Fernando Fernández-Aranda
Journal:  Sci Rep       Date:  2019-05-27       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.